Editor's Note This study by researchers at the University of Louisville finds that state mask mandates did not help slow COVID-19 transmission. The analysis compares COVID-19 case growth rates in 33 states that imposed statewide mask mandates on or before August 2, 2020, with states that imposed mask mandates after…
Editor's Note Two studies suggest that immunity to COVID-19 persists for at least a year and perhaps a lifetime, the May 26 New York Times reports. Researchers focused on memory B cells, which retain a memory of the COVID-19 virus. They found that even though the patients’ antibody levels fell…
Editor's Note A study by the Riken research institute and Kobe University using Fugaku, the world’s fastest supercomputer, finds that wearing two masks offers little benefit in preventing the spread of COVID-19 compared to one well-fitted disposable mask, the March 4 Reuters reports. The researchers found that tightly-fitted surgical masks…
Editor's Note Researchers from 17 healthcare organizations report that COVID-19 hospitalizations and death can be reduced with early outpatient treatments. The researchers designed an algorithm comprising treatments in order of disease severity: Immediately give zinc lozenges 5 times per day or zinc sulphate 220 mg every day for 5 days.…
Editor's Note This study by researchers at La Jolla Institute for Immunology, La Jolla, California, finds that T cells fight SARS-CoV-2 by targeting a broad range of sites on the virus, beyond the key sites on the spike protein. By attacking the virus from many angles, the T cells can…
Editor's Note This large US study of patients who contracted COVID-19 confirms and provides risk estimates for numerous complications of the disease. Using US health claims data of 70,288 patients who had a COVID-19-related healthcare visit between March 1 and April 30, 2020, researchers found that 53.4% were admitted to…
Editor's Note This study led by the National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, finds that vaccinations with mRNA-1273 (Moderna) have the potential to provide durable humoral immunity. This report describes immunogenicity data for mRNA-1273 at 119 days after the first vaccination and 90 days after the second…
Editor's Note This study of 1,848 US Marine Corps recruits finds that despite social distancing, wearing masks, regular handwashing, and other public health measures including strict quarantine, recruits contracted COVID-19 and spread it to others, even though hardly any of them had symptoms. Study participants were told to isolate themselves…
Editor's Note Moderna Inc (Cambridge, Massachusetts) on November 16 announced that its vaccine is 94.5% effective at preventing COVID-19. Their analysis of a 30,000-person trial (half received the vaccine and half received a placebo) finds that 90 of the 95 COVID-19 documented cases are in the placebo group. The Moderna announcement…
Editor's Note Researchers from the Massachusetts Institute of Technology, Cambridge, have developed an artificial intelligence (AI) tool that can detect COVID-19 by listening to patients’ coughs, regardless if they are symptomatic or not. To build the tool, the researchers solicited audio recordings of patients coughing and accompanying information about their…